GT Apeiron Therapeutics
Fred Aswad is an experienced professional in the field of biotechnology and pharmaceuticals, currently holding the position of Senior Vice President at Apeiron Therapeutics. With a background in Microbiology, Immunology, and Intellectual Property Law, Fred has held various leadership roles at companies such as IDEAYA Biosciences and Bayer. Fred's expertise spans across different areas of biology and research, making him a valuable asset in the industry.
This person is not in any offices
GT Apeiron Therapeutics
Apeiron Therapeutics intends to develop breakthrough investigational medicines by harnessing the power of artificial intelligence which drastically increases efficiency throughout the drug discovery process, from target selection, hit identification, lead optimization to pre-clinical studies and clinical trials.